INTRODUCTION
Quinazolinone derivatives represent one of the most active classes of compounds possessing a wide variety of biological activities viz. anti-parkinsonism, 1) anti-convulsant, 2, 3) hypoglycemic, 4) anti-HIV, 5) anthelminthic, 6) antibacterial, 7, 8) anticancer, 9) CNS depressant, 10) neuroleptic, 11) hypnotic 12) and analgesic 13) activity. We have synthesized and evaluated anticonvulsant and antimicrobial activity for a series of 3-phenyl-2-thioxo-2,3-dihydroquinazolin-4(1H)-ones and 3-napthyl-2-thioxoquinazolin-4-(3H) ones. In continuation of our work on these heterocycles with biological interest, we describe the synthesis and evaluation of analgesic, anti-in‰ammatory and ulcerogenic activities of some novel thioxoquinazolinones.
MATERIALS AND METHODS
Step 1. Synthesis of 3-substituted-2-thioxoquinazolin-4(3H)one 14, 15) A mixture of carbon disulˆde (30 mmoles) and the appropriate aromatic amines (12 mmoles) was added drop wise to the re‰uxed mixture of anthranilic acid (10 mmoles) and potassium hydroxide (12 mmoles) in methanol (10 ml). The mixture was heated under re‰ux for 3 h and the solid produced wasˆltered, washed with methanol and dried. The solid obtained was dissolved in potassium hydroxide solution (10％ w/v, 10 ml), ltered and then conc. HCl was added to theˆltrate. The white precipitate obtained wasˆltered, washed with water and dried. The crude product obtained was recrystallized from absolute ethanol (Scheme 1).
Step 2. Synthesis of Thioxoquinazolinone Derivatives by Mannich Reaction Various 3-substituted-2-thioxoquinazolin-4-(3H)-ones (80 mmoles) prepared in step 1 was dissolved in methanol in ice cold conditions. p-Hydroxy acetanilide, p-ethoxy Scheme 1. acetanilide, N (2, 3 xylyl) anthranilic acid, Sodium
[o-(2,6-dichloroanilino)phenyl] acetate, 80 mmoles each separately was added in a small quantity with constant stirring by using magnetic stirrer under ice cold conditions. A measured quantity of formaldehyde solution (80 mmoles) was added slowly with constant stirring for 4 h. The contents of the beaker were kept over night in a freezer. The crystallized product wasˆltered and dried. The crude product obtained was recrystallised from methanol (Scheme 1).
Melting points were determined in open capillaries in the electrical melting point apparatus and are uncorrected. Purity of the compounds was checked on silica gel coated Merck-TLC plates using water, chloroform, acetone and benzene as mobile phase. Visualization of spots was carried out in an iodine chamber. The structure of the synthesized compounds was elucidated from FT-IR (Shizamadu-8400 series) spectra in KBr disc and 1 H-NMR (Brucker-400 MHz) spectra in DMSO-d 6 16) was adopted for the determination of LD 50 value of the synthesized compounds. Albino mice of either sex (20 30 g) were used for this study. The animals were divided into 15 groups of 6 mice each. The synthesized compounds were injected intraperitoneally and the animals were observed for 2 h for death due to acute toxicity. LD 50 values were found to be 200 mg/kg. The doses of the test compounds were thenˆxed on the basis of their acute toxicity as 20 mg/kg for evaluation.
Evaluation of Anti-in‰ammatory Activity
Carrageenan Induced Rat Paw Edema method 17) was adopted for the study of anti-in‰ammatory activity. Albino Rats were divided into twelve groups, of six each. They were starved overnight with water prior to the day of experiment. Group-I served as control and was treated with vehicle (1％ CMC). Group-II was treated with Diclofenac sodium (10 mg/kg), Group-III, IV, V, VI, VII, VIII, IX, X, XI and XII was treated with test compounds (20 mg/kg) PTQ01, PTQ02, PTQ03, PTQ04, ETQ01, ETQ02, ETQ03, ETQ04, NTQ01 and NTQ02 respectively. All the test compounds were suspended in 1％ CMC and were administered orally 30 min before the carrageenan injection.
Acute in‰ammation was induced in each group by injecting 0.1 ml of 1％ w/v carrageenan into the sub plantar region of right hind jaw. The initial reading was taken at 0 h, i.e., immediately after injecting carrageenan and the procedure was repeated at 0.5, 1 and 2 h after carrageenan injection, with the help of Plethysmometer. Percentage inhibition of paw edema was calculated using the formula (Vt/Vc-1)×100 and tabulated ( Table 2) .
Analgesic Activity Eddy's hot plate method 18) was adopted for evaluation of analgesic activity.
Swiss strain albino mice of either sex weighing 25 30 g were used for this study. The test compounds were administered intraperitoneally in a dose of 20 mg/kg in 10％ v/v tween 80 suspensions. The animals were divided into 12 groups of 6 mice each. First group serves as control, second group was treated with pentazocin (5 mg/kg) and the remaining ten groups were administered intraperitoneally with the newly synthesized series of thioxoquinazolinone derivatives (20 mg/kg) respectively. The reaction time was noted for all groups on Eddy's hot plate before and after treatment of standard drug pentazocin and synthesized compounds. All the data (mean±S.E.M.) were analyzed statistically by student``t'' test and the values were recorded in Table 3 .
Ulcerogenic Potential Since gastric ulceration is considered to be main side eŠect of NSAIDs the ulcerogenic potential of the compounds PTQ01 and ETQ01 was investigated by Scibert et al. method. 19) Albino rats of either sex (160 180 g) were deprived of food for 12 h before administration of drug. First group (control) was treated with water, second group was treated with standard drug diclofenac sodium suspension (1％ sodium CMC) at a dose level of 5 mg /kg p.o., third and fourth group was treated with PTQ 01 and ETQ 01 suspension (1％ sodium CMC) at a dose level of 20 mg/kg p.o. After 6 h animals were sacriˆced and examined for haemmorhages and ulcers. Ulcer index was calculated.
RESULTS AND DISCUSSION
A series of 3-substituted-2-thioxoquinazolin-4(3H)-one derivatives have been synthesized by Mannich reaction. The compounds synthesized were in correlation with the expected structures. The titled compounds were evaluated for in vivo anti-in‰ammatory activity by carrageenan induced paw edema method at a dose of 20 mg/kg. All the compounds except ETQ03 exhibited anti-in‰ammatory activity. ( ( 2,6-dichlrophenyl ) ( 3-( 4-oxo-2-thioxo-3,4-dihydroquinazolin-1 ( 2H ) -yl ) methyl ) amino ) phenyl acetate (PTQ04) showed moderate anti-in‰ammato-ry activity. The compounds PTQ01, PTQ02, PTQ04, ETQ01 and ETQ02 showed signiˆcant analgesic activity compared with that of standard drug pentazocin. The synthesized compound PTQ01 and ETQ01 have the ulcer index 0.172±0.167 and 0.184±0.975 respectively, where as the standard drug showed 0.216 ±0.639. Therefore the synthesized compounds PTQ01 and ETQ01 where found less ulcerogenic than diclofenac, which reveals that it possess less GIT side eŠects.
